(Q44854833)

6 December 2017

The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil (English)

1 reference

6 December 2017

0 references

1 reference

1 reference

1

Norio Yasui-Furukori

1 reference

6 December 2017

Hanako Furukori

2

1 reference

6 December 2017

Ayako Kaneda

series ordinal

3

1 reference

6 December 2017

Sunao Kaneko

series ordinal

4

1 reference

6 December 2017

Tomonori Tateishi

series ordinal

5

1 reference

6 December 2017

1 May 2004

1 reference

The Journal of Clinical Pharmacology

6 December 2017

1 reference

6 December 2017

44

1 reference

6 December 2017

5

1 reference

6 December 2017

538-542

1 reference

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

6 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Herbal medicines and perioperative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Combination therapy for early Alzheimer's disease: what are we waiting for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Comparison of acetylcholinesterase determinations by the Michel and Ellman methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004264161

21 January 2018

Identifiers

DOI

10.1177/0091270004264161

1 reference

6 December 2017

1 reference